HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹106 Cr | ₹149 Cr | ₹97 Cr | ₹61 Cr | ₹83 Cr |
What is the latest Total Current Liabilities ratio of HESTER BIOSCIENCES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹106 Cr |
Mar2023 | ₹149 Cr |
Mar2022 | ₹97 Cr |
Mar2021 | ₹61 Cr |
Mar2020 | ₹83 Cr |
How is Total Current Liabilities of HESTER BIOSCIENCES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹106 Cr | -28.86 | |
Mar2023 | ₹149 Cr | 53.46 | |
Mar2022 | ₹97 Cr | 57.90 | |
Mar2021 | ₹61 Cr | -26.48 | |
Mar2020 | ₹83 Cr | - |
Compare Total Current Liabilities of peers of HESTER BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HESTER BIOSCIENCES | ₹1,503.9 Cr | 0.8% | 5.4% | -0.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,971.0 Cr | -7.3% | 1.1% | 15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,153.0 Cr | -3.5% | 12.9% | 53.4% | Stock Analytics | |
CIPLA | ₹122,717.0 Cr | 0.1% | 9.2% | 6.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,392.0 Cr | -1% | 0.2% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,702.0 Cr | 3.1% | 9.8% | -7.6% | Stock Analytics |
HESTER BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HESTER BIOSCIENCES | 0.8% |
5.4% |
-0.4% |
SENSEX | 0.6% |
11% |
10.4% |
You may also like the below Video Courses